IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Quince Therapeutics Inc COM

CUSIP: 22053A206 | 7 institutional holders

Quarters

Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Gen-Wealth Partners Inc33,018
0.0% of portfolio›$3.3K
Catalyst Funds Management Pty Ltd30,000
0.0% of portfolio›$3.0K
Fortitude Family Office, LLC8,095
0.0% of portfolio›$821
Advisory Services Network, LLC5,500
0.0% of portfolio›$558
Parallel Advisors, LLC795
0.0% of portfolio›$81
SBI Securities Co., Ltd.135
0.0% of portfolio›$14
StyleTurnoverLocationFiled
Gen-Wealth Partners Inc
33,018$3.3K0.0%CoreMediumZeeland, MI2026-05-08
Catalyst Funds Management Pty Ltd
30,000$3.0K0.0%GrowthVery HighSydney Nsw, China2026-05-11
Fortitude Family Office, LLC
8,095$8210.0%ETFMediumScottsdale, AZ2026-04-16
Advisory Services Network, LLC
5,500$5580.0%GrowthLowAtlanta, GA2026-05-15
Parallel Advisors, LLC
795$810.0%GrowthLowSan Francisco, CA2026-06-03
SBI Securities Co., Ltd.
135$140.0%GrowthLowTokyo, Mexico2026-04-28